课题基金 / 基金详情

IGF::OT::IGF STABILITY STUDY OF METHOTREXATE AND PLACEBO CAPSULES

IGF::OT::IGF STABILITY STUDY OF METHOTREXATE AND PLACEBO CAPSULES
甲氨蝶呤和安慰剂胶囊的 IGF::OT::IGF 稳定性研究
批准号:
9149464
负责人:
Jon Carl Mirsalis
金额:
$9.58万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2015
资助国家:
美国
项目状态:
已结题
起止时间:
2015-08-01 至 2018-11-30

项目摘要

项目成果

Jon Carl Mirsalis的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The Division of Acquired Immunodeficiency Syndromes (DAIDS) of the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Department of Health and Human Services (DHHS), maintains a portfolio of contracts to support the development of (1) therapies for HIV infection and its complications and coinfections, and (2) microbicides for preventing the sexual transmission of HIV. Services provided under this contracts assist investigators in academic settings and small pharmaceutical firms in filling specific gaps in their drug development plan as they advance their product towards clinical investigation. The goal of the program is to conduct studies to support the development of formulations of potential therapeutic agents and microbicides. Targeted formulations shall include tablets, capsules, lyophilized powders.,
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Task Order 3: Interventional Agent Development Services Program
  • 批准号:
    10704968
  • 项目类别:
  • 资助金额:
    $1.17万
  • 财政年份:
    2018
  • 负责人:
    Jon Carl Mirsalis
  • 依托单位:
Task Order 3:Interventional Agent Development Services Program
  • 批准号:
    9452777
  • 项目类别:
  • 资助金额:
    $47.24万
  • 财政年份:
    2017
  • 负责人:
    Jon Carl Mirsalis
  • 依托单位:
Task Order 5: The Interventional Agent Development Services Program
  • 批准号:
    9616145
  • 项目类别:
  • 资助金额:
    $8.95万
  • 财政年份:
    2017
  • 负责人:
    Jon Carl Mirsalis
  • 依托单位:
Task 4: The Interventional Agent Development Services program
  • 批准号:
    9430224
  • 项目类别:
  • 资助金额:
    $191.89万
  • 财政年份:
    2017
  • 负责人:
    Jon Carl Mirsalis
  • 依托单位:
海外基金